The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies
Crossref DOI link: https://doi.org/10.1038/s41375-018-0362-z
Published Online: 2019-01-25
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harding, Taylor
Baughn, Linda
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Van Ness, Brian
Text and Data Mining valid from 2019-01-25
Article History
Received: 13 August 2018
Revised: 25 October 2018
Accepted: 12 November 2018
First Online: 25 January 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.